Back
Product details:
CAS
1962925-29-6
Purity
95%
PF-03084014 inhibits the Notch signalling pathway. It contributes totumor suppression in breast, pancreatic carcinoma, hepatocellular carcinoma and progressive desmoid tumors.
Properties
Name
PF-03084014 Hydrobromide
Smiles
Br.CCC[C@H](N[C@H]1CCC=2C=C(F)C=C(F)C2C1)C(=O)NC3=CN(C=N3)C(C)(C)CNCC(C)(C)C
Targets
Please log in to see this information
Sold for research purposes under agreement from Pfizer Inc.
SDS
PF-3084014 | nirogacestat dihydrobromide
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$121
2 mg
$127
5 mg
$138
10 mg
$153
15 mg
$216
20 mg
$278
25 mg
$345
30 mg
$389
35 mg
$433
40 mg
$472
45 mg
$520
50 mg
$558
75 mg
$POA
100 mg
$POA
Quantity
1
Total amount
$ 138
PF-3084014 | nirogacestat dihydrobromide
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.